[77] Bolus doses in the range of 625 mg to 2.5 g (12.5–50 mg/kg) have been fatal. Premixed injection solutions are available and may help reduce dosage errors. For patients on diuretic therapy ...

and (extended or continuous or short or intermittent or bolus or prolonged or discontinuous) and (infusion). The bibliographies of all relevant articles were also hand-searched in order to ...

Give by IV bolus injection. Advise patients to seek immediate medical attention for a sudden loss of vision or hearing while on therapy. Pulmonary veno-occlusive disease: not recommended.

Initially 2mcg/kg/min by IV infusion; check aPTT 2hrs after starting. Titrate to 1.5–3x baseline aPTT (max 100sec); max 10mcg/kg/min. PCI with or at risk of HIT 350mcg/kg bolus by large bore IV ...

For decades, the most effective treatment for gastrointestinal cancers was a combination of two forms of 5-fluorouracil: the ...

Moreover, if an investigator can administer substances as a bolus injection, then one can study catheterized rats in free-living conditions by adding shielding on the tail arterial catheter ...

Insulcloud today announced its strategic expansion into the U.S. following FDA clearance for its Insulclock CAP smart device.

The Baylor Medicine Infusion Center offers patients an easy, attractive alternative to a hospital setting for receiving their infusion therapy, simplifying and expediting the process while providing ...

3D printing is all well and good if you want one of something, but if you want lots of plastic parts that are all largely identical, you should consider injection molding. You can pay someone to ...

PYLARIFY has made a profound impact on the lives of patients battling prostate cancer. It is the number one ordered PSMA PET imaging agent in the U.S., and is a proven diagnostic backed by real-world ...

Insulcloud, a pioneering healthtech company revolutionizing diabetes management, today announced its strategic expansion into the U.S. market following the FDA's clearance of its award-winning ...

LUNA and 4-year OPTIC data, alongside Phase 3 trial design updates, anticipated in Q4 2024- Appointed Jason Mitchell as chief ...